FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.
Jana Spes
Advertisement
Jana Spes is Vice-President, Technical Operations, Apotex, jspes@apotex.com.
Articles by Jana Spes
Advertisement
Latest Updated Articles
Quality Metrics and CMO AgreementPublished: May 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
